249 related articles for article (PubMed ID: 12086762)
1. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.
Biedermann BC; Sahner S; Gregor M; Tsakiris DA; Jeanneret C; Pober JS; Gratwohl A
Lancet; 2002 Jun; 359(9323):2078-83. PubMed ID: 12086762
[TBL] [Abstract][Full Text] [Related]
2. Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease.
Biedermann BC; Tsakiris DA; Gregor M; Pober JS; Gratwohl A
Bone Marrow Transplant; 2003 Dec; 32(11):1077-84. PubMed ID: 14625579
[TBL] [Abstract][Full Text] [Related]
3. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
[TBL] [Abstract][Full Text] [Related]
4. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelium as 'novel' target of graft-versus-host disease.
Tichelli A; Gratwohl A
Best Pract Res Clin Haematol; 2008 Jun; 21(2):139-48. PubMed ID: 18503982
[TBL] [Abstract][Full Text] [Related]
6. Endothelial-cell injury in cutaneous acute graft-versus-host disease.
Dumler JS; Beschorner WE; Farmer ER; Di Gennaro KA; Saral R; Santos GW
Am J Pathol; 1989 Dec; 135(6):1097-103. PubMed ID: 2596572
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease.
Shimura K; Ashihara E; Shimazaki C; Matsunaga S; Taniguchi K; Uchiyama H; Matsumoto Y; Kimura S; Matsubara H; Taniwaki M; Maekawa T
Biol Blood Marrow Transplant; 2008 Apr; 14(4):426-37. PubMed ID: 18342785
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelium and graft-versus-host disease.
Biedermann BC
Best Pract Res Clin Haematol; 2008 Jun; 21(2):129-38. PubMed ID: 18503981
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation.
Lai HY; Chou TY; Tzeng CH; Lee OK
Cell Transplant; 2012; 21(9):2033-45. PubMed ID: 22840591
[TBL] [Abstract][Full Text] [Related]
12. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
[TBL] [Abstract][Full Text] [Related]
13. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.
Parkman R
J Immunol; 1986 May; 136(10):3543-8. PubMed ID: 2871104
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation.
Shono Y; Shiratori S; Kosugi-Kanaya M; Ueha S; Sugita J; Shigematsu A; Kondo T; Hashimoto D; Fujimoto K; Endo T; Nishio M; Hashino S; Matsuno Y; Matsushima K; Tanaka J; Imamura M; Teshima T
Biol Blood Marrow Transplant; 2014 Apr; 20(4):495-500. PubMed ID: 24374213
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.
Yeh AC; Brunner AM; Spitzer TR; Chen YB; Coughlin E; McAfee S; Ballen K; Attar E; Caron M; Preffer FI; Yeap BY; Dey BR
Biol Blood Marrow Transplant; 2014 May; 20(5):730-4. PubMed ID: 24530972
[TBL] [Abstract][Full Text] [Related]
19. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
20. Role of CD8 Regulatory T Cells versus Tc1 and Tc17 Cells in the Development of Human Graft-versus-Host Disease.
Gutiérrez-Hoya A; López-Santiago R; Vela-Ojeda J; Montiel-Cervantes L; Rodríguez-Cortés O; Rosales-García V; Paredes-Cervantes V; Flores-Mejía R; Sandoval-Borrego D; Moreno-Lafont M
J Immunol Res; 2017; 2017():1236219. PubMed ID: 28164135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
